View Older Stories View More Recent Stories

May 15, 2025 08:58AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Mar 31
May 13, 2025 03:46PM Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
May 8, 2025 04:10PM Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
May 7, 2025 04:25PM Form SCHEDULE 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
May 7, 2025 04:21PM Form SCHEDULE 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
Mar 12, 2025 09:00AM Pentera Secures $60M to Lead Security Validation Market Consolidation and Drive Next Phase of Growth
Mar 7, 2025 09:47AM Form D/A FARALLON CAPITAL OFFSHOR
Mar 7, 2025 09:42AM Form D/A Farallon Capital Partner
Mar 7, 2025 09:37AM Form D/A Farallon Capital (AM)
Mar 7, 2025 09:32AM Form D/A Farallon Capital Institu
Mar 5, 2025 05:02PM Form SCHEDULE 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
Feb 18, 2025 03:37PM Form SCHEDULE 13G NEW YORK TIMES CO Filed by: Farallon Capital Partners, L.P.
Feb 18, 2025 03:37PM Form SCHEDULE 13G Aramark Filed by: Farallon Capital Partners, L.P.
Feb 14, 2025 09:01AM Form 13F-NT Farallon Capital Europe For: Dec 31
Feb 14, 2025 09:01AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Dec 31
Feb 14, 2025 09:00AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
Feb 14, 2025 08:59AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
Feb 14, 2025 08:59AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Feb 12, 2025 12:04AM Farallon Capital Builds Over 3% Position In Japan's Astellas- FT
Feb 11, 2025 05:14PM Form SCHEDULE 13G/A Savara Inc Filed by: Farallon Capital Partners, L.P.
Feb 11, 2025 12:11PM Form SCHEDULE 13G/A ENANTA PHARMACEUTICALS Filed by: Farallon Capital Partners, L.P.
Feb 10, 2025 08:21PM Bain Capital says it may withdraw tender offer proposal for Fuji Soft
Feb 10, 2025 02:33PM Form SCHEDULE 13G/A AleAnna, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 10, 2025 12:47PM Form SCHEDULE 13G/A Forte Biosciences, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 10, 2025 09:00AM Form SCHEDULE 13G/A Protagonist Therapeutics Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 07:31PM Form SCHEDULE 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 05:24PM Form SCHEDULE 13G/A NEW YORK TIMES CO Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 04:28PM Form SCHEDULE 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 5, 2025 01:10PM Form SCHEDULE 13G/A Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
Feb 4, 2025 12:02PM Form SCHEDULE 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
Feb 3, 2025 10:59PM KKR sweetens offer for Fuji Soft as bidding war with Bain goes another round
Feb 3, 2025 06:31AM Tectonic Therapeutic (TECX) Announces $185M Private Placement
Feb 3, 2025 06:30AM Tectonic Announces $185 Million Private Placement
Dec 19, 2024 04:01AM KKR extends tender offer period for Japan's Fuji Soft to Jan 9
Dec 17, 2024 07:43PM Bain and KKR battle for Fuji Soft heats up as Bain goes hostile
Dec 17, 2024 08:32AM Fuji Soft rejects Bain's raised buyout offer and sticks with KKR
Nov 26, 2024 01:08PM Nasdaq Private Market Announces 2024 Executive Leadership Team Promotions
Nov 26, 2024 05:23AM Explainer-What's behind the private equity battle for Fuji Soft?
Nov 14, 2024 08:22PM Form SC 13G Lantheus Holdings, Inc. Filed by: Farallon Capital Partners, L.P.
Nov 14, 2024 10:21AM Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
Nov 14, 2024 09:25AM Form 13F-NT Farallon Capital Europe For: Sep 30
Nov 14, 2024 09:24AM Form 13F-HR FARALLON CAPITAL MANAGEM For: Sep 30
Nov 8, 2024 05:15PM Form SC 13G/A Longboard Pharmaceutical Filed by: Farallon Capital Partners, L.P.
Nov 8, 2024 02:58PM Form SC 13G/A Aramark Filed by: Farallon Capital Partners, L.P.
Nov 8, 2024 02:41PM Form SC 13G/A AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
Nov 8, 2024 11:56AM Form SC 13G/A Elevation Oncology, Inc. Filed by: Farallon Capital Partners, L.P.
Nov 7, 2024 09:56AM Form SC 13G/A Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
Nov 6, 2024 08:20PM NexPoint Raises Concerns About UDF IV Board Allowing Millions in Management Fees to Enrich Former UDF Executives Imprisoned for Fraud
Nov 6, 2024 06:34PM Form SC 13G/A Savara Inc Filed by: Farallon Capital Partners, L.P.
Nov 6, 2024 05:06PM Form SC 13G/A Swiftmerge Acquisition Filed by: Farallon Capital Partners, L.P.
View More Recent Stories View Older Stories